XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
  Depression
  Neuropsychiatry
  Personality Disorders
  Bulimia
  Anxiety
  Substance Abuse
  Suicide
  CFS
  Psychoses
   Bipolar Disorder
   Schizophrenia
  Child Psychiatry
  Learning-Disabilities
  Psychology
  Forensic Psychiatry
  Mood Disorders
  Sleep Disorders
  Peri-Natal Psychiatry
  Psychotherapy
  Anorexia Nervosa
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
Search

Last Updated: Nov 17th, 2006 - 22:35:04

Schizophrenia Channel
subscribe to Schizophrenia newsletter

Latest Research : Psychiatry : Psychoses : Schizophrenia

   DISCUSS   |   EMAIL   |   PRINT
Nicotine could have a beneficial effect on the symptoms of schizophrenia
Mar 3, 2005, 18:05, Reviewed by: Dr.

The authors of the study comment that the findings do not generally support the self-medication hypothesis, but rather suggest a complex interaction between nicotine dependence and the symptoms of schizophrenia.

 
A new study has suggested that nicotine could have a beneficial effect on the symptoms of schizophrenia among mildly dependent smokers. However, people with schizophrenia who have high nicotine dependence are more likely to be readmitted to hospital and have a poor outcome.

Published in the March issue of the British Journal of Psychiatry, the study set out to explore the hypothesis that smoking is a form of 'self-medication' for people with schizophrenia.

Worldwide, schizophrenia is associated with a higher rate of smoking than that observed in the general population, or among those with other severe mental illnesses.

Although it has been suggested that smoking may have a beneficial effect on either schizophrenic symptoms, or on the side effects of antipsychotics drugs, research so far has been hampered by confounding factors, such as medication, or alcohol and drug use.

The study was carried out in two community mental health centres in Granada in Spain. 250 patients diagnosed with schizophrenia were classified into three categories: highly dependent smokers, mildly dependent smokers and non-smokers.

'Positive' symptoms of schizophrenia (e.g. delusions and hallucinations) and 'negative' symptoms (e.g. withdrawal and depression), and the number of admissions to hospital, were compared between the three groups.

69% of the patients studied were current smokers. It was found that high total and positive symptom levels were less frequent in mildly dependent smokers than in non-smokers or in highly dependent smokers. This finding supports the self-medication hypothesis for these symptoms in this group of patients.

Negative symptoms were not significantly associated with nicotine dependence, however, and so the self-medication hypothesis is not borne out in this respect.

Highly dependent smokers had the highest proportion of hospital admissions compared with mildly dependent smokers and non-smokers.

The authors of the study comment that the findings do not generally support the self-medication hypothesis, but rather suggest a complex interaction between nicotine dependence and the symptoms of schizophrenia.

If there is any beneficial effect of nicotine, it may be restricted to mildly dependent smokers, and particularly to those on low dosages of typical antipsychotics who are sensitive to the side effects of these older types of drug.
 

- Carmen Aguilar M, Gurpegui M, Diaz FJ and De Leon (2005) Nicotine dependence and symptoms in schizophrenia, British Journal of Psychiatry, 186, 215-221.
 

http://bjp.rcpsych.org/

 
Subscribe to Schizophrenia Newsletter
E-mail Address:

 



Related Schizophrenia News

Study aims to identify schizophrenics at risk for type 2 diabetes
Effects of ketamine mimic only some of the symptoms of schizophrenia
Association between famine and schizophrenia may yield clues about genetic basis
Neuropeptide S (NPS) may help in treating schizophrenia
Neuropeptide S (NPS) may help in treating schizophrenia
NMDA receptor hypofunction demonstrated in schizophrenia
Altered NRG1-erbB4 signaling may contribute to NMDA receptor hypofunction in schizophrenia
Transcription factor Elk-1's role in neurodegeneration and schizophrenia
Schizophrenia limits one's ability to perceive body language
Hospitalized schizophrenics are at a higher risk for developing medical/surgical complications


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us